Home The Word Brain	My Amedeo FAQ Privacy About	Flying Publisher
	COVID Reference, 4th edition, 372 pages + the daily Top 10

Gastric Cancer

Free Subscription Articles published in Br J Surg Retrieve available abstracts of 40 articles: HTML format

Single Articles

June 2020
1. KAMARAJAH SK, Navidi M, Griffin SM, Phillips AW, et al
   Impact of anastomotic leak on long-term survival in patients undergoing gastrectomy for gastric cancer.
   Br J Surg. 2020 Jun 13. doi: 10.1002/bjs.11749.
   PubMed     Abstract available
   
   
   
2. AN JY, Min JS, Hur H, Lee YJ, et al
   Laparoscopic sentinel node navigation surgery versus laparoscopic gastrectomy with lymph node dissection for early gastric cancer: short-term outcomes of a multicentre randomized controlled trial (SENORITA).
   Br J Surg. 2020 Jun 3. doi: 10.1002/bjs.11655.
   PubMed     Abstract available
   
   
   May 2020
3. RI M, Nunobe S, Honda M, Akimoto E, et al
   Gastrectomy with or without omentectomy for cT3-4 gastric cancer: a multicentre cohort study.
   Br J Surg. 2020 May 20. doi: 10.1002/bjs.11702.
   PubMed     Abstract available
   
   
   February 2020
4. ROH CK, Choi S, Seo WJ, Cho M, et al
   Indocyanine green fluorescence lymphography during gastrectomy after initial endoscopic submucosal dissection for early gastric cancer.
   Br J Surg. 2020 Feb 7. doi: 10.1002/bjs.11438.
   PubMed     Abstract available
   
   
   January 2020
5. 
   Randomized clinical trial of extensive intraoperative peritoneal lavage versus standard treatment for resectable advanced gastric cancer (CCOG 1102 trial).
   Br J Surg. 2020;107:120.
   PubMed    
   
   
   
6. SAUNDERS JH, Yanni F, Dorrington MS, Bowman CR, et al
   Impact of postoperative complications on disease recurrence and long-term survival following oesophagogastric cancer resection.
   Br J Surg. 2020;107:103-112.
   PubMed     Abstract available
   
   
   November 2019
7. DATTA J, Da Silva EM, Kandoth C, Song T, et al
   Poor survival after resection of early gastric cancer: extremes of survivorship analysis reveal distinct genomic profile.
   Br J Surg. 2019 Nov 25. doi: 10.1002/bjs.11443.
   PubMed     Abstract available
   
   
   October 2019
8. MISAWA K, Mochizuki Y, Sakai M, Teramoto H, et al
   Randomized clinical trial of extensive intraoperative peritoneal lavage versus standard treatment for resectable advanced gastric cancer (CCOG 1102 trial).
   Br J Surg. 2019 Oct 1. doi: 10.1002/bjs.11303.
   PubMed     Abstract available
   
   
   September 2019
9. ZHAO Z, Wang Y
   Comment on: Gene expression profiles for a prognostic immunoscore in gastric cancer.
   Br J Surg. 2019;106:1416.
   PubMed    
   
   
   August 2019
10. ALLUM WH, Smyth EC, Blazeby JM, Grabsch HI, et al
    Quality assurance of surgery in the randomized ST03 trial of perioperative chemotherapy in carcinoma of the stomach and gastro-oesophageal junction.
    Br J Surg. 2019;106:1204-1215.
    PubMed     Abstract available
    
    
    
11. LIN JX, Yoon C, Desiderio J, Yi BC, et al
    Development and validation of a staging system for gastric adenocarcinoma after neoadjuvant chemotherapy and gastrectomy with D2 lymphadenectomy.
    Br J Surg. 2019;106:1187-1196.
    PubMed     Abstract available
    
    
    July 2019
12. BROZA YY, Khatib S, Gharra A, Krilaviciute A, et al
    Screening for gastric cancer using exhaled breath samples.
    Br J Surg. 2019 Jul 1. doi: 10.1002/bjs.11294.
    PubMed     Abstract available
    
    
    June 2019
13. CHEN AH, Chan WH, Lee YH, Tseng JH, et al
    Routine chest CT for staging of gastric cancer.
    Br J Surg. 2019 Jun 18. doi: 10.1002/bjs.11186.
    PubMed     Abstract available
    
    
    
14. 
    Snapshot quiz.
    Br J Surg. 2019;106:878.
    PubMed    
    
    
    August 2018
15. VAN PUTTEN M, Nelen SD, Lemmens VEPP, Stoot JHMB, et al
    Overall survival before and after centralization of gastric cancer surgery in the Netherlands.
    Br J Surg. 2018 Aug 22. doi: 10.1002/bjs.10931.
    PubMed     Abstract available
    
    
    June 2018
16. NAVIDI M, Phillips AW, Griffin SM, Duffield KE, et al
    Cardiopulmonary fitness before and after neoadjuvant chemotherapy in patients with oesophagogastric cancer.
    Br J Surg. 2018;105:900-906.
    PubMed     Abstract available
    
    
    May 2018
17. KANDA M, Shimizu D, Tanaka H, Tanaka C, et al
    Synaptotagmin XIII expression and peritoneal metastasis in gastric cancer.
    Br J Surg. 2018 May 9. doi: 10.1002/bjs.10876.
    PubMed     Abstract available
    
    
    
18. CLAASSEN YHM, van Sandick JW, Hartgrink HH, Dikken JL, et al
    Association between hospital volume and quality of gastric cancer surgery in the CRITICS trial.
    Br J Surg. 2018;105:728-735.
    PubMed     Abstract available
    
    
    April 2018
19. ZENG D, Zhou R, Yu Y, Luo Y, et al
    Gene expression profiles for a prognostic immunoscore in gastric cancer.
    Br J Surg. 2018 Apr 25. doi: 10.1002/bjs.10871.
    PubMed     Abstract available
    
    
    
20. NELEN SD, Bosscha K, Lemmens VEPP, Hartgrink HH, et al
    Morbidity and mortality according to age following gastrectomy for gastric cancer.
    Br J Surg. 2018 Apr 23. doi: 10.1002/bjs.10836.
    PubMed     Abstract available
    
    
    
21. VAN DER KAAIJ RT, de Rooij MV, van Coevorden F, Voncken FEM, et al
    Using textbook outcome as a measure of quality of care in oesophagogastric cancer surgery.
    Br J Surg. 2018;105:561-569.
    PubMed     Abstract available
    
    
    January 2018
22. MARKAR SR, Mackenzie H, Wiggins T, Askari A, et al
    Influence of national centralization of oesophagogastric cancer on management and clinical outcome from emergency upper gastrointestinal conditions.
    Br J Surg. 2018;105:113-120.
    PubMed     Abstract available
    
    
    
23. POWELL AGMT, Soul S, Christian A, Lewis WG, et al
    Meta-analysis of the prognostic value of CpG island methylator phenotype in gastric cancer.
    Br J Surg. 2018;105:e61-e68.
    PubMed     Abstract available
    
    
    
24. VAN DER KAAIJ RT, van Kessel JP, van Dieren JM, Snaebjornsson P, et al
    Outcomes after prophylactic gastrectomy for hereditary diffuse gastric cancer.
    Br J Surg. 2018;105:e176-e182.
    PubMed     Abstract available
    
    
    December 2017
25. NOBLE F, Lloyd MA, Turkington R, Griffiths E, et al
    Multicentre cohort study to define and validate pathological assessment of response to neoadjuvant therapy in oesophagogastric adenocarcinoma.
    Br J Surg. 2017;104:1816-1828.
    PubMed     Abstract available
    
    
    
26. KAWAKATSU S, Ohashi M, Hiki N, Nunobe S, et al
    Use of endoscopy to determine the resection margin during laparoscopic gastrectomy for cancer.
    Br J Surg. 2017;104:1829-1836.
    PubMed     Abstract available
    
    
    November 2017
27. POLOM K, Marano L, Marrelli D, De Luca R, et al
    Meta-analysis of microsatellite instability in relation to clinicopathological characteristics and overall survival in gastric cancer.
    Br J Surg. 2017 Nov 1. doi: 10.1002/bjs.10663.
    PubMed     Abstract available
    
    
    October 2017
28. DENG J, Guo J, Ma G, Zhang H, et al
    Prognostic value of the cancer oncogene Kelch-like 6 in gastric cancer.
    Br J Surg. 2017 Oct 17. doi: 10.1002/bjs.10628.
    PubMed     Abstract available
    
    
    September 2017
29. KJAER DW, Larsson H, Svendsen LB, Jensen LS, et al
    Changes in treatment and outcome of oesophageal cancer in Denmark between 2004 and 2013.
    Br J Surg. 2017;104:1338-1345.
    PubMed     Abstract available
    
    
    August 2017
30. NELEN SD, van Putten M, Lemmens VEPP, Bosscha K, et al
    Effect of age on rates of palliative surgery and chemotherapy use in patients with locally advanced or metastatic gastric cancer.
    Br J Surg. 2017 Aug 9. doi: 10.1002/bjs.10621.
    PubMed     Abstract available
    
    
    
31. WANG ZX, Li GX, Zhou ZW, Huang ZP, et al
    Validation of a nomogram for selecting patients for chemotherapy after D2 gastrectomy for cancer.
    Br J Surg. 2017;104:1226-1234.
    PubMed     Abstract available
    
    
    May 2017
32. LIN C, Liu H, Zhang H, Cao Y, et al
    Tryptase expression as a prognostic marker in patients with resected gastric cancer.
    Br J Surg. 2017 May 24. doi: 10.1002/bjs.10546.
    PubMed     Abstract available
    
    
    
33. BENCIVENGA M, Verlato G, Han DS, Marrelli D, et al
    Validation of two prognostic models for recurrence and survival after radical gastrectomy for gastric cancer.
    Br J Surg. 2017 May 10. doi: 10.1002/bjs.10551.
    PubMed     Abstract available
    
    
    
34. BUSWEILER LA, Schouwenburg MG, van Berge Henegouwen MI, Kolfschoten NE, et al
    Textbook outcome as a composite measure in oesophagogastric cancer surgery.
    Br J Surg. 2017;104:742-750.
    PubMed     Abstract available
    
    
    February 2017
35. CHANG JS, Kim KH, Yoon HI, Hyung WJ, et al
    Locoregional relapse after gastrectomy with D2 lymphadenectomy for gastric cancer.
    Br J Surg. 2017 Feb 28. doi: 10.1002/bjs.10502.
    PubMed     Abstract available
    
    
    
36. TOKUNAGA M, Ito S, Yoshikawa T, Nunobe S, et al
    Prognostic factors for survival in patients with pT1 N+ or T2-3 N0 gastric cancer in Japan.
    Br J Surg. 2017 Feb 27. doi: 10.1002/bjs.10509.
    PubMed     Abstract available
    
    
    January 2017
37. IDA S, Hiki N, Cho H, Sakamaki K, et al
    Randomized clinical trial comparing standard diet with perioperative oral immunonutrition in total gastrectomy for gastric cancer.
    Br J Surg. 2017 Jan 10. doi: 10.1002/bjs.10417.
    PubMed     Abstract available
    
    
    
38. TAKAGANE A, Mohri Y, Konishi T, Fukushima R, et al
    Randomized clinical trial of 24 versus 72 h antimicrobial prophylaxis in patients undergoing open total gastrectomy for gastric cancer.
    Br J Surg. 2017;104:e158-e164.
    PubMed     Abstract available
    
    
    December 2016
39. YANG HK
    Gastric cancer from operating theatre to bench in Korea.
    Br J Surg. 2016;103:e193.
    PubMed    
    
    
    
40. BUSWEILER LA, Wijnhoven BP, van Berge Henegouwen MI, Henneman D, et al
    Early outcomes from the Dutch Upper Gastrointestinal Cancer Audit.
    Br J Surg. 2016;103:1855-1863.
    PubMed     Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Gastric Cancer is free of charge. This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim. Design: